Balance and Gait Disorders Associated with Genetic Inheritance in PD

$229,269P50FY2015NSNIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Paper 39557903 Paper 39399688 Paper 39314957 Paper 38888142 Paper 38870440 Paper 38853953 Paper 38436140 Paper 37972450 Paper 37964373 Paper 37279935 Paper 37252677 Paper 37010072 Paper 36511519 Paper 36394592 Paper 35808984 Paper 35779041 Paper 35448464 Paper 35357463 Paper 35121993 Paper 35099792 Paper 35093191 Paper 34961556 Paper 34910503 Paper 34408160 Paper 34382643 Paper 34355669 Paper 34310044 Paper 34032594 Paper 33938021 Paper 33818911 Paper 33646154 Paper 33584497 Paper 33579999 Paper 33497263 Paper 33484978 Paper 33298513 Paper 33292899 Paper 33252618 Paper 33239300 Paper 33180719 Paper 33106633 Paper 33013627 Paper 33000167 Paper 32961131 Paper 32937003 Paper 32885039 Paper 32775508 Paper 32741842 Paper 32641150 Paper 32620863 Paper 32566740 Paper 32559629 Paper 32139977 Paper 32065223 Paper 31970213 Paper 31941827 Paper 31731260 Paper 31633026 Paper 31629653 Paper 31403079 Paper 31392412 Paper 31362787 Paper 31177941 Paper 31131605 Paper 30958379 Paper 30924200 Paper 30909225 Paper 30826425 Paper 30796007 Paper 30776152 Paper 30685501 Paper 30660957 Paper 30584162 Paper 30465796 Paper 30452409 Paper 30216541 Paper 30056417 Paper 30052535 Paper 29892607 Paper 29793507 Paper 29572994 Paper 29486463 Paper 29478836 Paper 29478701 Paper 29456161 Paper 29311311 Paper 29163119 Paper 28846090 Paper 28807493 Paper 28699334 Paper 28644039 Paper 28594877 Paper 28538087 Paper 28526295 Paper 28453469 Paper 28336296 Paper 28319654 Paper 28270762 Paper 28268100 Paper 28215728

Abstract

PROJECT 3 (HORAK): ABSTRACT Balance/gait disorders associated with genetic inheritance in PD Cognitive deficits and balance/gait (B&G) disorders are both progressive but heterogeneous among people with Parkinson's disease (PD), and may be due in part to genetic factors. The inaugural PANUC award demonstrated that APOE ?4 or GBA variants increases the risk for different types of cognitive impairment in PD. Project 3 will test the hypothesis that the pattern of B&G abnormalities, in part an expression of various types of cognitive impairment, differ in PD subjects with APOE ?4, GBA variants, or neither. B&G will be characterized in all Clinical Core participants using novel, inertial-sensors worn on the feet, belt, and wrist. A quick Instrumented Stand and Walk protocol that involves standing quietly for 30 seconds, followed by step- initiation, a 2-minute walk, and several 180 degree turns quantifies various domains of mobility disability, such as postural sway area, gait pace, and gait rhythm. The B&G protocol will also be repeated during simultaneous performance of a quantitative cognitive task to determine the effects of divided attention on B&G. We will test our hypotheses with three specific aims: 1) Cross-sectional: Determine patterns of B&G dysfunction in PD with APOE ?4, GBA variants, or neither, and relate B&G to cognitive impairments in these genetically-defined subsets of PD; 2) Physiological: Relate central cholinergic tone, measured with SAI, to impairments of B&G and attention in in genetically-defined subsets of PD; and 3) Longitudinal: Determine the longitudinal decline of B&G, attention, and cholinergic tone in genetically-defined subsets of PD. This work is significant because it will expand our knowledge of genetic risk for severity and decline in mobility as they relate to cognitive impairments in PD, and lay the foundation for potential cholinergic mechanisms linking cognitive with B&G dysfunction. Insights from this project, integrated within the PANUC, will provide new biomarkers for cognitive and mobility decline for better prognosis and interventions for patients with PD.

View original record on NIH RePORTER →